Community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: Cost-effectiveness, mortality, and morbidity reduction analysis

International Journal of Gynecology and Obstetrics

Volumn 108, Issue 3, 2010, Pages 289-294

  Sutherland, Tori ^a   Meyer, Carinne ^b   Bishai, David M ^c   Geller, Stacie ^d   Miller, Suellen ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Anemia; Cost effectiveness; Maternal mortality; Misoprostol; Postpartum hemorrhage

Indexed keywords

MISOPROSTOL; OXYTOCIN; PLACEBO;

ANEMIA; ARTICLE; ATTRIBUTABLE RISK; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG MARKETING; FEMALE; HEALTH CARE PLANNING; HOME DELIVERY; HUMAN; INDIA; LABOR MANAGEMENT; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL MORTALITY; MONTE CARLO METHOD; PATIENT TRANSPORT; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; RISK REDUCTION; RURAL AREA; SCALE UP; TRADITIONAL MEDICINE; TREATMENT RESPONSE;

EID: 76049110718     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.11.007     Document Type: Article

References (35)

1. Hill K., Thomas K., AbouZahr C., Walker N., Say L., Inoue M., et al. Estimates of maternal mortality worldwide between 1990 and 2005: an assessment of available data. Lancet 370 9595 (2007) 1311-1319
2. Prata N., Graff M., Graves A., and Potts M. Avoidable maternal deaths: Three ways to help now. Glob Public Health 4 6 (2009) 575-587
3. International Institue of Population Studies. National Family Health Survey (NFHS-3), 2005-06, India vol. I (2007), IIPS, Mumbai
4. Maharaj D. Puerperal pyrexia: a review. Part I. Obstet Gynecol Surv 62 6 (2007) 393-399
5. World Health Organization. Unedited Draft Report of the 17th Expert Committee on the Selection and Use of Essential Medicines (2009), WHO, Geneva
6. Derman R.J., Kodkany B.S., Goudar S.S., Gellar S.E., Naik V.A., Bellad M.D., et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 368 9543 (2006) 1248-1253
7. Hoj L., Cardoso P., Nielsen B.B., Hvidman L., Nielsen J., and Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 331 7519 (2005) 723
8. Walraven G., Blum J., Dampha Y., Sowe M., Morison L., Winikoff B., et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG 112 9 (2005) 1277-1283
9. Alfirevic Z., Blum J., Walraven G., Weeks A., and Winikoff B. Prevention of postpartum hemorrhage with misoprostol. Int J Gynecol Obstet 99 Suppl 2 (2007) S198-S201
10. International Confederation of Midwives and International Federation of Gynaecology and Obstetrics. Prevention and treatment of post-partum haemorrhage: New advances for low resource settings. Int J Gynecol Obstet 97 2 (2007) 160-163
11. Prata N., Mbaruku G., Campbell M., Potts M., and Vahidnia F. Controlling postpartum hemorrhage after home births in Tanzania. Int J Gynaecol Obstet 90 1 (2005) 51-55
12. Sanghvi H., Changpong G., Fishel J., Ahmed S., and Zulkarnin M. Prevention of Postpartum Hemorrhage Study, West Java, Indonesia (2004), JHPIEGO, Baltimore
13. Sutherland T., and Bishai D.M. Cost-effectiveness of misoprostol and prenatal iron supplementation as maternal mortality interventions in home births in rural India. Int J Gynecol Obstet 104 3 (2009) 189-193
14. Blum J. Development of evidence-based regimens on misoprostol. Current evidence: Misoprostol for PPH treatment. Misoprostol for prevention and treatment of post-partum hemorrhage (PPH): Current knowledge and future directions (2009), Gates Foundation, Seattle
15. Alfirevic Z., and Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev (2006) CD001338
16. Blum J., Alfirevic Z., Walraven G., Weeks A., and Winikoff B. Treatment of postpartum hemorrhage with misoprostol. Int J Gynecol Obstet 99 Suppl 2 (2007) S202-S205
17. Miller S., Tudor C., Thorsten V., Nyima, Kalyang, Sonam, et al. Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet. J Midwifery Womens Health 54 2 (2009) 133-141.e1
18. AbouZahr C. Maternal Mortality in 2000: Estimates developed by WHO, UNICEF and UNFPA (2003), World Health Organization, Geneva
19. Barnett S., Nair N., Tripathy P., Borghi J., Rath S., and Costello A. A prospective key informant surveillance system to measure maternal mortality - findings from indigenous populations in Jharkhand and Orissa, India. BMC Pregnancy Childbirth 8 (2008) 6
20. Khan K.S., Wojdyla D., Say L., Gulmezoglu A.M., and Van Look P.F. WHO analysis of causes of maternal death: a systematic review. Lancet 367 9516 (2006) 1066-1074
21. Banks E., Meirik O., Farley T., Akande O., Bathija H., and Ali M. Female genital mutilation and obstetric outcome: WHO collaborative prospective study in six African countries. Lancet 367 9525 (2006) 1835-1841
22. McCord C., Premkumar R., Arole S., and Arole R. Efficient and effective emergency obstetric care in a rural Indian community where most deliveries are at home. Int J Gynecol Obstet 75 3 (2001) 297-307 discussion 308-9
23. In: McFayden J.E. (Ed). International drug price indicator guide (2006), Management Sciences for Health, Boston
24. Bradley S.E., Prata N., Young-Lin N., and Bishai D.M. Cost-effectiveness of misoprostol to control postpartum hemorrhage in low-resource settings. Int J Gynecol Obstet 97 1 (2007) 52-56
25. Assisstance Afghanistan. Appeal for Afghanistan profile of submissions under thermatic group (1999), Assistance Afghanistan
26. Fauveau V., Stewart K., Khan S.A., and Chakraborty J. Effect on mortality of community-based maternity-care programme in rural Bangladesh. Lancet 338 8776 (1991) 1183-1186
27. AIM for SEVA. Proposal for maternal and child health care along with mobile dispensary. All India Movement for Seva (2005)
28. Drummond M., O'Brien B., Stoddart G., and Torrance G. Methods for the Economic Evaluation of Health Care Programmes. Second Edition (1997), Oxford University Press, London
29. Bhat P.N. Maternal mortality in India: an update. Stud Fam Plann 33 3 (2002) 227-236
30. Murray C., and Lopez A. The Global Burden of Disease (1996), Harvard Press, Cambridge
31. Ministry of Health and Family Welfare, Govt. of India: Uttar Pradesh vital statistics. Available at: http://www.mohfw.nic.in/NRHM/State%20Files.up.htm. Accessed June 12, 2009.
32. World Health Organization. Making Choices in Health: WHO Guide to Cost Effectiveness Analysis (2003), World Health Organization, Geneva
33. Chow J., Darley S., and Laxminarayan R. Cost-effectiveness of disease interventions in India (2007), Resources for the Future, Washington DC
34. Briggs A.H. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 17 5 (2000) 479-500
35. Patel A., Goudar S.S., Geller S.E., Kodkany B.S., Edlavitch S.A., Wagh K., et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynecol Obstet 93 3 (2006) 220-224